We are live on ! Find out more
DPA

Devon Park Associates Portfolio holdings

AUM $30.8M
1-Year Est. Return 0.85%
This Fund
S&P 500
This Quarter Est. Return
+14.62%
1 Year Est. Return
+0.85%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$131M
AUM Growth
Cap. Flow
+$121M
Cap. Flow %
92.35%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 18.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZSPH
1
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$107M 81.67%
+2,576,723
New +$102M
TVRD
2
Tvardi Therapeutics
TVRD
$19.7M
$11.5M 8.76%
+31,997
New +$10.3M
CEMP
3
DELISTED
Cempra, Inc.
CEMP
$9.17M 6.99%
+390,144
New +$5.83M
TARA icon
4
Protara Therapeutics
TARA
$220M
$3.39M 2.58%
+8,143
New +$3.28M

Similar funds

Devon Park Associates's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Devon Park Associates, which disclosed 4 positions worth $131M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is ZS PHARMA INC COMS TK (DE): 2,576,723 shares worth $107M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets.

  • Devon Park Associates's largest Q4 2014 buy was ZS PHARMA INC COMS TK (DE): 2,576,723 shares worth $107M.
  • Devon Park Associates's ten largest holdings make up 100% of its $131M portfolio in Q4 2014.
  • Devon Park Associates disclosed 4 positions in Q4 2014, its first 13F filing on record.

Based on Devon Park Associates's 13F filing for Q4 2014, filed 13 Feb 2015.